Fresenius Medical Care AG : Release of a capital market information

Fresenius Medical Care Medical Care AG: Share buyback

Disclosure pursuant to Art. 5 para. 1 lit. b) of Regulation (EU) No. 596/2014

Share buyback – Interim Report

In the period from July 13, 2026 to July 17, 2026 (each inclusive), 336,000 shares were bought back within the framework of the first tranche of the share buyback of Fresenius Medical Care Medical Care AG, the start of which was disclosed on May 28, 2026, pursuant to Art. 5 para. 1 lit. a) of Regulation (EU) No. 596/2014, Art. 2 para. 1 of Delegated Regulation (EU) 2016/1052.

Shares were bought back as follows:

Date	Acquired shares (number)	Weighted average price (in EUR)	Transaction volume (in EUR)	Trading venue
13 July 2026	31,000	42.3704	1,313,482.40	XETR
14 July 2026	1,000	42.5343	42,534.30	XETR
15 July 2026	140,000	41.5538	5,817,532.00	XETR
16 July 2026	84,000	41.9386	3,522,842.40	XETR
17 July 2026	80,000	42.2066	3,376,528.00	XETR

A total of 3,294,040 shares has been acquired within the framework of the first tranche of the share buyback.

The purchase of the shares is carried out by a credit institution commissioned by Fresenius Medical Care Medical Care AG.

Fresenius Medical Care Medical Care AG will provide regular information regarding the progress of the share buyback, including by posting its required disclosures at https://freseniusmedicalcare.com/en/investors/shares/share-buyback/.